was successfully added to your cart.

Your SEO optimized title page contents

Marijuana Federal Reclassification: District Court to Decide On

Federal Spending Bill allows for Medical Marijuana

Marijuana Federal Reclassification

Marijuana has been an illegal Schedule I drug since 1970. But on Monday, Oct. 27, a judge in the Eastern District of California heard testimony regarding this classification’s constitutionality and potentially could bring about a marijuana federal reclassification.

In a highly unusual move, Judge Kimberly J. Mueller granted the evidentiary hearing on a motion challenging the statute in April, and set a date in September.

Three medical experts have testified that modern scientific evidence has rendered the Schedule I ruling unconstitutional as the drug is not as threatening it has been made out to be.

Doctors Gregory Carter, MD and Carl Hart, Ph.D. testified that marijuana is one of the safest therapeutic substances, and Philip Denny, MD backed up those claims.

Bertha Madras, Ph.D. and former deputy Drug Czar under President George W. Bush argued on behalf of the government that cannabis fails to measure up as medicine, equating the drug to heroin, as humans no longer smoke it for pain relief.

Hearings are scheduled through Oct. 29 and a decision could come by the end of the week.


About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

Leave a Reply